Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
An effectiveness result of 50 per cent achieved during the peak delta variant Covid-19 wave in India, in a highrisk study population of physicians and healthcare workers, in a hospital environment, provides insights into the efficacy and effectiveness of Covaxin
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
Subscribe To Our Newsletter & Stay Updated
